How to buy SI-BONE stock | $30.17

SI-BONE, Inc is a medical devices business based in the US. SI-BONE shares (SIBN) are listed on the NASDAQ and all prices are listed in US Dollars. SI-BONE employs 295 staff and has a trailing 12-month revenue of around 0.00.

SI-BONE stock price (NASDAQ: SIBN)

Use our graph to track the performance of SIBN stocks over time.

SI-BONE shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$30.17
52-week range	$17.16 - $37.21
50-day moving average	$30.65
200-day moving average	$31.42
Wall St. target price	$41.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.53

Buy SI-BONE shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy SI-BONE stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of SI-BONE, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SI-BONE price performance over time

Historical closes compared with the close of $30.17 from 2021-05-28

1 week (2021-07-24)	N/A
1 month (2021-07-02)	-2.05%
3 months (2021-05-04)	-8.58%
6 months (2021-01-31)	N/A

1 year (2020-07-31)	N/A
2 years (2019-07-31)	N/A
3 years (2018-07-31)	N/A
5 years (2016-07-31)	N/A

SI-BONE financials

Revenue TTM	$77 million
Gross profit TTM	$64.5 million
Return on assets TTM	-12.66%
Return on equity TTM	-31.06%
Profit margin	-56.06%
Book value	$4.93
Market capitalisation	$970.2 million

TTM: trailing 12 months

Shorting SI-BONE shares

There are currently 1.2 million SI-BONE shares held short by investors – that's known as SI-BONE's "short interest". This figure is 10.6% up from 1.0 million last month.

There are a few different ways that this level of interest in shorting SI-BONE shares can be evaluated.

SI-BONE's "short interest ratio" (SIR)

SI-BONE's "short interest ratio" (SIR) is the quantity of SI-BONE shares currently shorted divided by the average quantity of SI-BONE shares traded daily (recently around 285841.83168317). SI-BONE's SIR currently stands at 4.04. In other words for every 100,000 SI-BONE shares traded daily on the market, roughly 4040 shares are currently held short.

However SI-BONE's short interest can also be evaluated against the total number of SI-BONE shares, or, against the total number of tradable SI-BONE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SI-BONE's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 SI-BONE shares in existence, roughly 30 shares are currently held short) or 0.0326% of the tradable shares (for every 100,000 tradable SI-BONE shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SI-BONE.

Find out more about how you can short SI-BONE stock.

SI-BONE share dividends

We're not expecting SI-BONE to pay a dividend over the next 12 months.

SI-BONE share price volatility

Over the last 12 months, SI-BONE's shares have ranged in value from as little as $17.16 up to $37.21. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SI-BONE's is 1.4326. This would suggest that SI-BONE's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

SI-BONE overview

SI-BONE, Inc. , a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. .

Frequently asked questions

What percentage of SI-BONE is owned by insiders or institutions?
Currently 1.9% of SI-BONE shares are held by insiders and 101.599% by institutions. How many people work for SI-BONE?
Latest data suggests 295 work at SI-BONE. When does the fiscal year end for SI-BONE?
SI-BONE's fiscal year ends in December. Where is SI-BONE based?
SI-BONE's address is: 471 El Camino Real, Santa Clara, CA, United States, 95050 What is SI-BONE's ISIN number?
SI-BONE's international securities identification number is: US8257041090 What is SI-BONE's CUSIP number?
SI-BONE's Committee on Uniform Securities Identification Procedures number is: 825704109